Autoimmune gastrointestinal dysmotility: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Autoimmune gastrointestinal dysmotility | |||
| synonyms = AGID | |||
| field = [[Gastroenterology]], [[Neurology]], [[Immunology]] | |||
| symptoms = [[Nausea]], [[vomiting]], [[abdominal pain]], [[bloating]], [[constipation]], [[diarrhea]] | |||
| complications = [[Malnutrition]], [[dehydration]], [[intestinal obstruction]] | |||
| onset = Variable | |||
| duration = Chronic | |||
| causes = [[Autoimmune disease]] | |||
| risks = [[Autoimmune disorders]], [[genetic predisposition]] | |||
| diagnosis = [[Clinical evaluation]], [[antibody testing]], [[gastrointestinal motility studies]] | |||
| differential = [[Irritable bowel syndrome]], [[gastroparesis]], [[chronic intestinal pseudo-obstruction]] | |||
| treatment = [[Immunosuppressive therapy]], [[prokinetic agents]], [[dietary modifications]] | |||
| medication = [[Corticosteroids]], [[immunomodulators]], [[antiemetics]] | |||
| prognosis = Variable, depends on response to treatment | |||
| frequency = Rare | |||
}} | |||
{{Short description|A disorder affecting gastrointestinal motility due to autoimmune causes}} | {{Short description|A disorder affecting gastrointestinal motility due to autoimmune causes}} | ||
'''Autoimmune gastrointestinal dysmotility''' (AGID) is a rare disorder characterized by abnormal movement of the muscles in the gastrointestinal tract due to an autoimmune response. This condition can affect any part of the gastrointestinal tract, leading to a variety of symptoms and complications. | '''Autoimmune gastrointestinal dysmotility''' (AGID) is a rare disorder characterized by abnormal movement of the muscles in the gastrointestinal tract due to an autoimmune response. This condition can affect any part of the gastrointestinal tract, leading to a variety of symptoms and complications. | ||
==Pathophysiology== | ==Pathophysiology== | ||
AGID occurs when the body's immune system mistakenly attacks the nerves and muscles of the gastrointestinal tract. This autoimmune attack can lead to inflammation and damage to the [[enteric nervous system]], which is responsible for controlling the motility of the gastrointestinal tract. The resulting dysmotility can cause either slowed or uncoordinated movement of the digestive tract, affecting the normal process of digestion and absorption. | AGID occurs when the body's immune system mistakenly attacks the nerves and muscles of the gastrointestinal tract. This autoimmune attack can lead to inflammation and damage to the [[enteric nervous system]], which is responsible for controlling the motility of the gastrointestinal tract. The resulting dysmotility can cause either slowed or uncoordinated movement of the digestive tract, affecting the normal process of digestion and absorption. | ||
==Symptoms== | ==Symptoms== | ||
The symptoms of AGID can vary widely depending on which part of the gastrointestinal tract is affected. Common symptoms include: | The symptoms of AGID can vary widely depending on which part of the gastrointestinal tract is affected. Common symptoms include: | ||
| Line 16: | Line 31: | ||
* [[Weight loss]] | * [[Weight loss]] | ||
* [[Malnutrition]] | * [[Malnutrition]] | ||
These symptoms can lead to significant discomfort and may severely impact a patient's quality of life. | These symptoms can lead to significant discomfort and may severely impact a patient's quality of life. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosing AGID can be challenging due to its rarity and the overlap of symptoms with other gastrointestinal disorders. A comprehensive evaluation typically includes: | Diagnosing AGID can be challenging due to its rarity and the overlap of symptoms with other gastrointestinal disorders. A comprehensive evaluation typically includes: | ||
| Line 26: | Line 39: | ||
* [[Gastrointestinal motility]] studies | * [[Gastrointestinal motility]] studies | ||
* [[Endoscopy]] to visualize the gastrointestinal tract | * [[Endoscopy]] to visualize the gastrointestinal tract | ||
==Treatment== | ==Treatment== | ||
Treatment of AGID focuses on managing symptoms and addressing the underlying autoimmune process. Therapeutic approaches may include: | Treatment of AGID focuses on managing symptoms and addressing the underlying autoimmune process. Therapeutic approaches may include: | ||
| Line 33: | Line 45: | ||
* Nutritional support, including [[enteral nutrition]] or [[parenteral nutrition]] if necessary | * Nutritional support, including [[enteral nutrition]] or [[parenteral nutrition]] if necessary | ||
* Symptomatic treatment for nausea, pain, and other symptoms | * Symptomatic treatment for nausea, pain, and other symptoms | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with AGID varies depending on the severity of the condition and the response to treatment. Early diagnosis and appropriate management can improve outcomes and quality of life for many patients. | The prognosis for individuals with AGID varies depending on the severity of the condition and the response to treatment. Early diagnosis and appropriate management can improve outcomes and quality of life for many patients. | ||
==Related pages== | ==Related pages== | ||
* [[Autoimmune disease]] | * [[Autoimmune disease]] | ||
| Line 42: | Line 52: | ||
* [[Dysmotility]] | * [[Dysmotility]] | ||
* [[Enteric nervous system]] | * [[Enteric nervous system]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Gastrointestinal tract disorders]] | [[Category:Gastrointestinal tract disorders]] | ||
Latest revision as of 22:24, 3 April 2025
| Autoimmune gastrointestinal dysmotility | |
|---|---|
| Synonyms | AGID |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Nausea, vomiting, abdominal pain, bloating, constipation, diarrhea |
| Complications | Malnutrition, dehydration, intestinal obstruction |
| Onset | Variable |
| Duration | Chronic |
| Types | N/A |
| Causes | Autoimmune disease |
| Risks | Autoimmune disorders, genetic predisposition |
| Diagnosis | Clinical evaluation, antibody testing, gastrointestinal motility studies |
| Differential diagnosis | Irritable bowel syndrome, gastroparesis, chronic intestinal pseudo-obstruction |
| Prevention | N/A |
| Treatment | Immunosuppressive therapy, prokinetic agents, dietary modifications |
| Medication | Corticosteroids, immunomodulators, antiemetics |
| Prognosis | Variable, depends on response to treatment |
| Frequency | Rare |
| Deaths | N/A |
A disorder affecting gastrointestinal motility due to autoimmune causes
Autoimmune gastrointestinal dysmotility (AGID) is a rare disorder characterized by abnormal movement of the muscles in the gastrointestinal tract due to an autoimmune response. This condition can affect any part of the gastrointestinal tract, leading to a variety of symptoms and complications.
Pathophysiology[edit]
AGID occurs when the body's immune system mistakenly attacks the nerves and muscles of the gastrointestinal tract. This autoimmune attack can lead to inflammation and damage to the enteric nervous system, which is responsible for controlling the motility of the gastrointestinal tract. The resulting dysmotility can cause either slowed or uncoordinated movement of the digestive tract, affecting the normal process of digestion and absorption.
Symptoms[edit]
The symptoms of AGID can vary widely depending on which part of the gastrointestinal tract is affected. Common symptoms include:
These symptoms can lead to significant discomfort and may severely impact a patient's quality of life.
Diagnosis[edit]
Diagnosing AGID can be challenging due to its rarity and the overlap of symptoms with other gastrointestinal disorders. A comprehensive evaluation typically includes:
- Detailed medical history and physical examination
- Blood tests to identify specific autoantibodies
- Imaging studies such as CT scan or MRI
- Gastrointestinal motility studies
- Endoscopy to visualize the gastrointestinal tract
Treatment[edit]
Treatment of AGID focuses on managing symptoms and addressing the underlying autoimmune process. Therapeutic approaches may include:
- Immunosuppressive therapy to reduce the autoimmune response
- Medications to improve gastrointestinal motility, such as prokinetic agents
- Nutritional support, including enteral nutrition or parenteral nutrition if necessary
- Symptomatic treatment for nausea, pain, and other symptoms
Prognosis[edit]
The prognosis for individuals with AGID varies depending on the severity of the condition and the response to treatment. Early diagnosis and appropriate management can improve outcomes and quality of life for many patients.